The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | Quantifying time toxicity in lung cancer trials with Time Toxicity Units
Amanda Herrmann, MD, University of California San Diego, La Jolla, CA, explores the concept of time toxicity in lung cancer clinical trials, focusing on the development of a standardized metric to quantify the time burden on patients. In a retrospective analysis of 26 trials of targeted therapies, time toxicity was measured in Time Toxicity Units (TTUs). Findings suggest an increase in time toxicity over time, highlighting the importance of minimizing time toxicity to enhance patient enrollment and streamline clinical trial protocols. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
